---
title: Christian Angermeiers contributions to psychedelic research
videoId: bRm6TEkM1Jw
---

From: [[jessemichels]] <br/> 

Christian Angermeier is an entrepreneur, investor, and head of Apearone, which manages 3.5 billion in assets <a class="yt-timestamp" data-t="00:00:14">[00:00:14]</a>. He is widely recognized for his early investment in Compass Pathways and his founding of Atai Life Sciences <a class="yt-timestamp" data-t="00:00:23">[00:00:23]</a>. Angermeier is dedicated to systematically [[history_and_marginalization_of_psychedelics | demarginalizing psychedelics]] and integrating them into mainstream medicine through FDA approval <a class="yt-timestamp" data-t="00:00:29">[00:00:29]</a>.

## Personal Journey into Psychedelics

Despite growing up in Bavaria where alcohol is common, Angermeier lived a "straight edge" life, never trying alcohol, cigarettes, or cannabis before the age of 34 <a class="yt-timestamp" data-t="00:00:55">[00:00:55]</a>. At 34, he tried magic mushrooms, which he described as the "single most meaningful thing" he had ever done <a class="yt-timestamp" data-t="00:02:07">[00:02:07]</a>. This experience led to a revelation that these substances should be medically available <a class="yt-timestamp" data-t="00:02:14">[00:02:14]</a>.

His confidence to try psychedelics was bolstered by meeting a neuroscientist from the University of Mannheim, Germany, who had completed his PhD with Albert Hofmann, the "legendary LSD guy" <a class="yt-timestamp" data-t="00:02:24">[00:02:24]</a>. This scientist introduced Angermeier to the medical applications of [[psychedelics_and_mental_health_treatment | psychedelics]] a year before his first personal trip <a class="yt-timestamp" data-t="00:02:41">[00:02:41]</a>.

He emphasizes that while psychedelics offer significant benefits, he does not believe they should be "broadly given out" or used recreationally in a way that makes them easily accessible <a class="yt-timestamp" data-t="00:03:10">[00:03:10]</a>.

## Key Ventures: Compass Pathways and Atai Life Sciences

Angermeier's work focuses on obtaining FDA approval for [[psychedelics_and_mental_health_treatment | psychedelics]] to treat ailments such as addiction, depression, and PTSD <a class="yt-timestamp" data-t="00:00:33">[00:00:33]</a>.

### Compass Pathways
Compass Pathways is a company focused on psilocybin, the active ingredient in magic mushrooms <a class="yt-timestamp" data-t="00:04:43">[00:04:43]</a>. Its primary focus is on treatment-resistant depression <a class="yt-timestamp" data-t="00:04:48">[00:04:48]</a>. Angermeier expressed surprise at the openness of regulators and politicians towards this research <a class="yt-timestamp" data-t="00:04:53">[00:04:53]</a>. This openness is attributed to the legitimacy of the science and the severe global mental health crisis <a class="yt-timestamp" data-t="00:04:53">[00:04:53]</a>.

### Atai Life Sciences
Atai Life Sciences was founded because Compass Pathways aimed to remain focused solely on psilocybin <a class="yt-timestamp" data-t="00:04:58">[00:04:58]</a>. Seeing a wider range of psychedelics like ketamine, LSD, MDMA, and DMT, Angermeier decided to create Atai to capture and develop all commercially viable psychedelics <a class="yt-timestamp" data-t="00:04:35">[00:04:35]</a>. Atai serves as a broader platform, with Compass representing an initial foundational investment within it <a class="yt-timestamp" data-t="00:05:04">[00:05:04]</a>.

## Addressing the Mental Health Crisis

Angermeier notes the significant scale of the mental health crisis, with hundreds of millions of people suffering from depression, anxiety, addiction, and PTSD <a class="yt-timestamp" data-t="00:04:10">[00:04:10]</a>. This widespread suffering creates pressure on regulators to find effective solutions <a class="yt-timestamp" data-t="00:04:27">[00:04:27]</a>.

He identifies three pillars crucial for human well-being that are currently eroding, contributing to the rise in mental health issues:
1.  **Faith/Religion:** People are "permanently terrified of dying" and the death of loved ones. Religion and faith offer a counterbalance to this "nagging terror" <a class="yt-timestamp" data-t="00:08:39">[00:08:39]</a>.
2.  **Purpose:** Humans desire purpose, to be needed, included, and to understand their daily activities and broader existence <a class="yt-timestamp" data-t="00:09:09">[00:09:09]</a>. Technological innovation threatens this, potentially eliminating a majority of jobs within 10-20 years, leading to a "futurephobia" <a class="yt-timestamp" data-t="00:09:40">[00:09:40]</a>.
3.  **Love/Relationships:** The erosion of communities and the concept of "loneliness" (a word originating in Victorian England during the Industrial Revolution) contribute to mental health decline <a class="yt-timestamp" data-t="00:10:17">[00:10:17]</a>. Loneliness leads to severe health issues and significantly earlier deaths in older adults <a class="yt-timestamp" data-t="00:10:50">[00:10:50]</a>.

Angermeier strongly believes that people in nursing homes should undergo a medically assisted [[psychedelics_and_mental_health_treatment | psychedelic trip]] once or twice a year to mitigate loneliness and improve well-being <a class="yt-timestamp" data-t="00:11:12">[00:11:12]</a>.

## Historical Context of Psychedelics

Angermeier discusses the [[history_and_marginalization_of_psychedelics | marginalization of psychedelics]], acknowledging Michael Pollan's narrative that their association with 1960s counterculture led to their discreditation <a class="yt-timestamp" data-t="00:05:22">[00:05:22]</a>. While psilocybin was once legal medication for depression in some countries, mental health issues were less prevalent and harder to diagnose back then <a class="yt-timestamp" data-t="00:05:57">[00:05:57]</a>. The government "abused" this association to demonize the hippie movement and its opposition to the Vietnam War, portraying drug users as "crazy" to invalidate their dissent <a class="yt-timestamp" data-t="00:06:37">[00:06:37]</a>.

He highlights the work of Brian Muraresku, author of "The Immortality Key," who argues that [[the_role_of_psychedelics_in_historical_and_modern_contexts | psychedelics]] have been used for thousands of years <a class="yt-timestamp" data-t="00:07:02">[00:07:02]</a>. Figures like Plato and Aristotle are believed to have partaken in [[ritualized_psychedelic_trips_in_Western_civilization | ritualized psychedelic trips]] at Eleusis, near Athens, returning with profound insights and a diminished fear of death <a class="yt-timestamp" data-t="00:07:07">[00:07:07]</a>. This aligns with modern applications of psilocybin, which can help terminally ill patients fear death less <a class="yt-timestamp" data-t="00:07:25">[00:07:25]</a>.

Angermeier posits that [[psychedelics_and_their_potential_influence_on_religious_practices | psychedelic experiences]] often have a spiritual dimension <a class="yt-timestamp" data-t="00:07:57">[00:07:57]</a>. Muraresku's work provides "proof" that ancient spiritual leaders and founders of religions likely used these substances, leading Angermeier to interpret religious texts, such as the burning bush Moses encountered, as clear indications of DMT use <a class="yt-timestamp" data-t="00:08:06">[00:08:06]</a>.